VERADIGM INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2009-12-04: Form 8-K; Period of report 2009-11-30; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2009-10-05: Form 8-K; Period of report 2009-10-05; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2009-09-29: Form 8-K; Period of report 2009-09-29; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2009-08-11: Form 8-K; Period of report 2009-08-04; Description 8.01 Other Events; Details 8.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2009-12-04 | 8-K | 2009-11-30 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 (d) On November 30, 2009, the Nominating and Governance Committee of the Board of Directors (the “Board”) of Allscripts-Misys Healthcare Solutions, Inc. (“Allscripts” or the “Company”) appointed Stephen Wilson as a member of the Board pursuant to Article Seventh, Section 7(d) of the Company’s Certificate of Incorporation and Article V, Section 4 of the Company’s Bylaws, effective immediately. | d8k.htm |
| 2009-10-05 | 8-K | 2009-10-05 | 7.01 Regulation FD Disclosure | 7.01 Attached as Exhibit 99.1 hereto is an Investor Presentation dated October 2009, which is incorporated herein by reference. | d8k.htm |
| 2009-09-29 | 8-K | 2009-09-29 | 2.02 Results of Operations and Financial Condition | 2.02 On September 29, 2009, Allscripts-Misys Healthcare Solutions, Inc. announced its earnings for the three months ended August 31, 2009. | d8k.htm |
| 2009-08-11 | 8-K | 2009-08-04 | 8.01 Other Events | 8.01 On July 1, 2009, Allscripts-Misys Healthcare Solutions, Inc. (“Allscripts” or the “Company”) sent a notice of redemption for all of its outstanding 3.50% Convertible Senior Debentures Due 2024 (the “Debentures”) at a redemption price equal to 100% of the principal amount of the Debentures, plus interest accrued and unpaid to, but excluding, August 5, 2009 (the redemption date). | d8k.htm |
| 2009-08-11 | 8-K/A | 2009-06-01 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 As previously disclosed, on June 2, 2009, Eileen McPartland was appointed Chief Operating Officer of Allscripts. | d8ka.htm |
| 2009-07-22 | 8-K | 2009-07-20 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 On July 20, 2009, Allscripts-Misys Healthcare Solutions, Inc. held its fiscal 2009 fourth quarter earnings conference call. 7.01 Attached as Exhibit 99.2 hereto is an Investor Presentation dated July 2009, which is incorporated herein by reference. | d8k.htm |
| 2009-07-20 | 8-K | 2009-07-20 | 2.02 Results of Operations and Financial Condition | 2.02 On July 20, 2009, Allscripts-Misys Healthcare Solutions, Inc. announced its earnings for the three and twelve months ended May 31, 2009. | d8k.htm |
| 2009-06-25 | 8-K | 2009-06-24 | 2.02 Results of Operations and Financial Condition | 2.02 On June 24, 2009, Allscripts-Misys Healthcare Solutions, Inc. (“Allscripts”) announced that it will report its financial results for the three months and fiscal year ended May 31, 2009 after the stock market closes on Monday, July 20, 2009 and its management will host a conference call and webcast at 4:30 p.m. | d8k.htm |
| 2009-06-02 | 8-K | 2009-06-01 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On June 1, 2009, Eileen McPartland was appointed the Chief Operating Officer of Allscripts-Misys Healthcare Solutions, Inc. (“Allscripts”). | d8k.htm |
| 2009-04-29 | 8-K | 2009-04-29 | 8.01 Other Events | 8.01 As part of an effort to diversify their personal holdings Glen Tullman, Chief Executive Officer of Allscripts-Misys Healthcare Solutions Inc. (“Allscripts”), and other members of management, including four other executive officers of Allscripts, each adopted written stock trading plans (the “Trading Plans”) in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (“Rule 10b5-1”), as well as Allscripts’ insider trading policies. | d8k.htm |
| 2009-04-24 | 8-K | 2009-04-24 | 7.01 Regulation FD Disclosure | 7.01 Attached as Exhibit 99.1 hereto is an Investor Presentation dated April 2009, which is incorporated herein by reference. | d8k.htm |
| 2009-04-07 | 8-K | 2009-04-07 | 7.01 Regulation FD Disclosure | 7.01 Attached as Exhibit 99.1 hereto is an Investor Presentation dated April 2009, which is incorporated herein by reference. | d8k.htm |
| 2009-04-02 | 8-K | 2009-04-02 | 2.02 Results of Operations and Financial Condition | 2.02 On April 2, 2009, Allscripts-Misys Healthcare Solutions, Inc. announced its earnings for the three and nine months ended February 28, 2009. | d8k.htm |
| 2009-03-09 | 8-K | 2009-03-09 | 8.01 Other Events | 8.01 On March 9, 2009, Allscripts-Misys Healthcare Solutions, Inc. (“Allscripts-Misys”) announced that Allscripts, LLC (“Allscripts”), a wholly-owned subsidiary of Allscripts-Misys, entered into an Asset Purchase Agreement (the “Sale Agreement”) with A-S Medication Solutions LLC (“Buyer”), pursuant to which Allscripts has agreed to sell to Buyer certain assets comprising Allscripts’ Medication Services business (the “Assets”). | d8k.htm |
| 2009-03-05 | 8-K | 2009-03-01 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | d8k.htm |
| 2009-02-11 | 8-K | 2009-02-10 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 2.03 The information set forth above in Item 1.01 of this Current Report on Form 8-K with respect to Credit Facility is incorporated by reference into this Item 2.03. 8.01 On February 10, 2009, the Company issued a press release announcing that its Board of Directors approved a stock repurchase program under which the Company may purchase up to $150 million of its common stock over the next two years. | d8k.htm |
| 2009-01-12 | 8-K | 2009-01-12 | 7.01 Regulation FD Disclosure | 7.01 Attached as Exhibit 99.1 hereto is an Investor Presentation dated January 2009, which is incorporated herein by reference. | d8k.htm |
| 2009-01-09 | 8-K/A | 2008-10-10 | 7.01 Regulation FD Disclosure | 7.01 Attached as Exhibit 99.3 is non-GAAP summary quarterly information for each of the four quarters in the year ended May 31, 2008 and for the three months ended August 31, 2008, combining the results of operations of Allscripts and MHS. | d8ka.htm |
| 2009-01-08 | 8-K | 2009-01-08 | 2.02 Results of Operations and Financial Condition | 2.02 On January 8, 2009, Allscripts-Misys Healthcare Solutions, Inc. announced its earnings for the three and six months ended November 30, 2008. | d8k.htm |